Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct;183(10):4499-4506.
doi: 10.1007/s00431-024-05690-5. Epub 2024 Aug 15.

E148Q variant: a familial Mediterranean fever-causing mutation or a sequence variant?

Elham Orouk Awaad #  1   2 , Lana Khoury #  1   2 , Joeri W van Straalen  3 , Adi Miller-Barmak  1   2 , Tal Gazitt  4   5   2 , Jumana Haddad-Haloun  6 , Riva Brik  1   2 , Mohamad Hamad Saied  7   8   9
Affiliations

E148Q variant: a familial Mediterranean fever-causing mutation or a sequence variant?

Elham Orouk Awaad et al. Eur J Pediatr. 2024 Oct.

Abstract

Familial Mediterranean fever (FMF) is an autosomal recessive autoinflammatory disease, linked to mutations in the MEFV gene. The p.E148Q variant, found on exon 2, has an uncertain role in FMF, with debates on whether it is a benign polymorphism or a pathogenic mutation. This study aimed to assess the clinical characteristics and severity of FMF in patients homozygous for the p.E148Q variant and to evaluate the impact of the p.V726A variant in these patients. This retrospective cohort study analyzed data from electronic medical records at Carmel Medical Center, Israel. Patients who underwent genetic testing for FMF from November 2004 to December 2019 and had p.E148Q/p.E148Q or p.E148Q/p.E148Q + p.V726A variants were included. Disease severity was assessed using the Tel Hashomer Key to Severity Score. Statistical analyses compared clinical characteristics and severity between genotype groups. The study included 61 FMF patients, with 24 (39%) having p.E148Q/p.E148Q and 37 (61%) having p.E148Q/p.E148Q + p.V726A variants. The majority (72%) were Druze. Most patients (65.5%) exhibited mild disease, while 31.1% had moderate disease, with no cases of severe disease. Colchicine treatment significantly reduced CRP levels in all patients.

Conclusion: These findings suggest that the p.E148Q variant, whether alone or with p.V726A, generally results in mild to moderate FMF severity, supporting its pathogenic role in particular ethnicity. These results contribute to understanding the clinical significance of the p.E148Q variant and considering the patient's need for Colchicine treatment.

What is known: • The role of the p.E148Q variant in FMF is debated, with questions about whether it is a benign polymorphism or a pathogenic mutation. • The prevalence of MEFV variants can vary significantly among different ethnic groups.

What is new: • The p.E148Q variant has clinical significance in particular ethnicities, as supported by a significant reduction in CRP levels following colchicine treatment. • The p.E148Q variant, whether alone or with p.V726A, generally results in mild to moderate FMF severity.

Keywords: Druze; Ethnicity; FMF; Familial Mediterranean fever; p.E148Q; p.V726A.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Stacked bar plots of disease severity in FMF patients (n = 59) of different descent, stratified by MEFV mutation
Fig. 2
Fig. 2
Paired boxplots of CRP levels before and after colchicine treatment, stratified by MEFV mutation
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Kucuk A, Gezer IA lbayra., Ucar R, Karahan AY avu. Familial Mediterranean fever. Acta medica (Hradec Kral [Internet]. 2014 [cited 2024 Jun 5];57(3):97–104. Available from: https://pubmed-ncbi-nlm-nih-gov.carmelmc.idm.oclc.org/25649364/ - PubMed
    1. Sari I, Birlik M, Kasifoglu T. Familial Mediterranean fever: an updated review. Eur J Rheumatol [Internet]. 2014 Mar 7 [cited 2024 Jun 5];1(1):21–33. Available from: https://pubmed-ncbi-nlm-nih-gov.carmelmc.idm.oclc.org/27708867/ - PMC - PubMed
    1. Sohar E, Gafni J PM. Tel Hashomer key to severity score for FMF. In: First international conference of FMF. London, Tel Aviv: Freund Publishing House; 1997.
    1. Alghamdi M. Familial Mediterranean fever, review of the literature. Clin Rheumatol [Internet]. 2017 Aug 1 [cited 2024 Jun 6];36(8):1707–13. Available from: https://pubmed-ncbi-nlm-nih-gov.carmelmc.idm.oclc.org/28624931/ - PubMed
    1. Chae JJ, Cho YH, Lee GS, Cheng J, Liu PP, Feigenbaum L, et al. Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice. Immunity [Internet]. 2011 May 27 [cited 2024 Jun 6];34(5):755–68. Available from: https://pubmed-ncbi-nlm-nih-gov.carmelmc.idm.oclc.org/21600797/ - PMC - PubMed

LinkOut - more resources